Literature DB >> 17368633

Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.

Cindy Berthelot1, Mary C Dickerson, Peter Rady, Qin He, Farhad Niroomand, Stephen K Tyring, Amit G Pandya.   

Abstract

Epidermodysplasia verruciformis (EV) is a rare disorder characterized by widespread human papillomavirus infection and malignant transformation. EV may be caused by mutations of the genes EVER1 or EVER2, which are located on the EV1 locus, 17q25. We describe a patient with EV and a novel homozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17368633     DOI： 10.1016/j.jaad.2007.01.036

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  12 in total

Review 1.  Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.

Authors:  Antona J Wagstaff; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Epidermodysplasia verruciformis: An early and unusual presentation.

Authors:  Ilteris Murat Emsen; M Esref Kabalar
Journal:  Can J Plast Surg       Date:  2010

Review 3.  [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].

Authors:  A Heratizadeh; B Völker; E Kupsch; K Wichmann; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

Review 4.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

5.  Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.

Authors:  Anita S Patel; Margaret R Karagas; Michael Pawlita; Tim Waterboer; Heather H Nelson
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

6.  Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections.

Authors:  Amandine Crequer; Anja Troeger; Etienne Patin; Cindy S Ma; Capucine Picard; Vincent Pedergnana; Claire Fieschi; Annick Lim; Avinash Abhyankar; Laure Gineau; Ingrid Mueller-Fleckenstein; Monika Schmidt; Alain Taieb; James Krueger; Laurent Abel; Stuart G Tangye; Gérard Orth; David A Williams; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

7.  Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.

Authors:  Rui Yoshida; Toshihiko Kato; Masahiko Kawase; Mariko Honda; Tsuyoshi Mitsuishi
Journal:  BMC Dermatol       Date:  2014-07-21

Review 8.  The EVER genes - the genetic etiology of carcinogenesis in epidermodysplasia verruciformis and a possible role in non-epidermodysplasia verruciformis patients.

Authors:  Agnieszka Kalińska-Bienias; Cezary Kowalewski; Sławomir Majewski
Journal:  Postepy Dermatol Alergol       Date:  2016-05-16       Impact factor: 1.837

9.  Sk India Quiz 26: Hypopigmented papules in a human immunodeficiency virus-positive patient.

Authors:  Lalit Kumar Gupta; Manisha Balai; Ashok Kumar Khare; Asit Mittal
Journal:  Indian Dermatol Online J       Date:  2016 Jul-Aug

10.  Inherited MST1 deficiency underlies susceptibility to EV-HPV infections.

Authors:  Amandine Crequer; Capucine Picard; Etienne Patin; Aurelia D'Amico; Avinash Abhyankar; Martine Munzer; Marianne Debré; Shen-Ying Zhang; Geneviève de Saint-Basile; Alain Fischer; Laurent Abel; Gérard Orth; Jean-Laurent Casanova; Emmanuelle Jouanguy
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.